ATLASAscendis Pharma A/S (ASND) earnings date: Nov 11, 2026
Ascendis Pharma A/S (ASND) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 11, 2026. Analysts expect EPS of $1.13.
Source: company filings and exchange data · Updated Nov 2, 2026
Ascendis Pharma A/S reports on Nov 11, 2026. One email the day before, with ATLAS’s read on Ascendis Pharma A/S. You can switch it off at any time.
Alert me before ASND reportsFree to start. Creating an account takes under a minute.
ASND earnings at a glance
| Next report (confirmed) | Wed, Nov 11, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | $1.13 |
| Last report | Aug 13, 2026 · Beat |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +88.8% |
| Average move around a report | ±2.2% (last 5) |
| Sector | Healthcare · Biotechnology |
Ascendis Pharma A/S earnings history: last 5 reports
Ascendis Pharma A/S last reported on Aug 13, 2026: EPS of $0.90 against an estimate of $0.77 (+16.9% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 13, 2026 | $0.77 | $0.90 | +16.9% | Beat | -2.7% |
| Jul 18, 2026 | $0.39 | $0.38 | -2.6% | Miss | -2.2% |
| May 7, 2026 | -$0.08 | $0.27 | +437.5% | Beat | +1.2% |
| Apr 9, 2026 | -$0.07 | -$0.08 | -14.3% | Miss | +2.6% |
| Mar 19, 2026 | $0.16 | $0.17 | +6.3% | Beat | -2.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
ATLAS view on ASND before the report
| Last price | $251.27 (-0.7%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 50% |
| Likely 1-month range (50%) | $237.06 – $266.82 |
| Normal 1-day range (±1σ) | ±2.0% |
| ATLAS fair value | $92.93 ($67.73 – $131.76) · price is 170% above |
These figures come from the same calibrated model and valuation as the Ascendis Pharma A/S stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Get the full ATLAS analysis for ASND
See the fair value, the probability range and the earnings history of Ascendis Pharma A/S on its ATLAS page.
Ascendis Pharma A/S (ASND) stock analysisPlans from €3.99 a month.
Ascendis Pharma A/S earnings: frequently asked questions
When does Ascendis Pharma A/S (ASND) report earnings?
Ascendis Pharma A/S is scheduled to report on Wednesday, November 11, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for ASND?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is $1.13 per share (USD). Estimates can change before the report.
How often does ASND beat earnings estimates?
Of its last 5 reports with a recorded result, Ascendis Pharma A/S beat the EPS estimate 3 times; the average surprise was +88.8%. Past results do not predict the next one.
How much does ASND move around earnings?
Over its last 5 reports the stock moved an average of 2.2% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Ascendis Pharma A/S beat earnings estimates last quarter?
Ascendis Pharma A/S last reported on Aug 13, 2026: EPS of $0.90 against an estimate of $0.77 (+16.9% surprise), a beat.
How much does ASND usually move in a day?
On a normal trading day the ATLAS model puts ASND’s one-day range at about ±2.0%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 11, 2026
Educational information, not investment advice. Disclaimer